Larry Lundmark

Title: Larry Lundmark: Innovator in Transdermal Drug Delivery

Introduction

Larry Lundmark is an accomplished inventor based in Brooklyn Park, MN (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent focused on transdermal applications. His work has the potential to enhance the effectiveness of drug administration, making it a vital area of research and development.

Latest Patents

Lundmark holds a patent for a composition for transdermal drug delivery. This patent describes a gelation reaction product created from a mixture of an organic polysaccharide gum, polyethylene glycol, and m-, p-, or o-hydroxybenzoic acid. The composition is designed to form a gel that possesses adhesive properties, allowing it to adhere to the skin while being pliant enough to conform to body contours. This innovation is crucial for improving the delivery of medications through the skin.

Career Highlights

Larry Lundmark is associated with Minnetonka, Inc., where he has been instrumental in advancing research in drug delivery technologies. His expertise and innovative mindset have contributed to the company's reputation as a leader in the field. With a focus on practical applications, Lundmark's work continues to influence the development of effective transdermal systems.

Collaborations

Lundmark collaborates with Richard Reever, leveraging their combined expertise to push the boundaries of drug delivery research. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in the industry.

Conclusion

Larry Lundmark's contributions to transdermal drug delivery highlight his role as a key innovator in the field. His patent and ongoing work at Minnetonka, Inc. demonstrate the potential for advancements in medication administration. Through collaboration and dedication, Lundmark continues to pave the way for future innovations in healthcare.